4 drug, devicemakers in the headlines

Here are four drug and medical device companies that made headlines in the past week.

Advertisement

1. Baxter recalls frozen Intralipid shipment: 4 things to know
Baxter International on Thursday recalled one shipment of Intralipid due to temperature control issues.

2. Jury orders AbbVie to pay $140M+ for misrepresenting testosterone drug risks
AbbVie must pay more than $140 million to a Tennessee man who says he experienced a heart attack after taking the company’s testosterone replacement drug AndroGel, a federal jury ruled Oct. 5.

3. J&J exits insulin pump business: 4 things to know
Johnson & Johnson’s insulin pump unit, Animas Corp., will shutter business operations in the U.S. and Canada, effective immediately.  

4. Medtronic estimates $250M earnings loss from Hurricane Maria: 4 things to know
Medtronic expects supply chain disruptions caused by Hurricane Maria to cost the company up to $250 million in the second quarter of fiscal year 2018, which ends Oct. 27.

More articles on supply chain:
FDA commissioner: High drug prices are a ‘public health concern the FDA should address’
Judge ruling allows drug ‘price gouging’ law to take effect in Maryland
Rite Aid names former Walgreens executive as president, COO

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.